<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Pharm</journal-id><journal-id journal-id-type="iso-abbrev">Int J Pharm</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>International journal of pharmaceutics</journal-title></journal-title-group><issn pub-type="ppub">0378-5173</issn><issn pub-type="epub">1873-3476</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10362388</article-id><article-id pub-id-type="pmcid-ver">PMC10362388.1</article-id><article-id pub-id-type="pmcaid">10362388</article-id><article-id pub-id-type="pmcaiid">10362388</article-id><article-id pub-id-type="manuscript-id">NIHMS1894879</article-id><article-id pub-id-type="pmid">37059242</article-id><article-id pub-id-type="doi">10.1016/j.ijpharm.2023.122951</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1894879</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1894879</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Meta-Analysis of Material Properties Influencing Nanoparticle Plasma Pharmacokinetics</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Macedo</surname><given-names initials="B">Briana</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Patel</surname><given-names initials="M">Manthan</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zaleski</surname><given-names initials="MH">Michael H.</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mody</surname><given-names initials="P">Parth</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ma</surname><given-names initials="X">Xiaonan</given-names></name><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mei</surname><given-names initials="P">Patrick</given-names></name><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Myerson</surname><given-names initials="JW">Jacob W.</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Brenner</surname><given-names initials="JS">Jacob S.</given-names></name><xref rid="A3" ref-type="aff">3</xref><xref rid="A4" ref-type="aff">4</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Glassman</surname><given-names initials="PM">Patrick M.</given-names></name><xref rid="A5" ref-type="aff">5</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Computer Science, Princeton University, Princeton, NJ, USA</aff><aff id="A2"><label>2</label>Department of Chemical and Biological Engineering, Drexel University, Philadelphia, USA</aff><aff id="A3"><label>3</label>Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA</aff><aff id="A4"><label>4</label>Division of Pulmonary and Critical Care Medicine, University of Pennsylvania, Philadelphia, PA, USA</aff><aff id="A5"><label>5</label>Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA, USA</aff><author-notes><corresp id="CR1"><label>*</label><bold>Corresponding Author Contact Information:</bold> Jacob S. Brenner: <email>jacob.brenner@pennmedicine.upenn.edu</email>; 215-662-2222; 3450 Hamilton Walk Stemmler Building, Office #220 Philadelphia, PA, USA 19104; Patrick M. Glassman: <email>patrick.glassman@temple.edu</email>; 215-707-0355; 3307 N. Broad Street, 559B Pharmacy and Allied Health, Philaedlphia, PA 19140</corresp><fn fn-type="COI-statement" id="FN2"><p id="P43">Declaration of interests</p><p id="P44">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p></fn></author-notes><pub-date pub-type="ppub"><day>25</day><month>5</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>12</day><month>4</month><year>2023</year></pub-date><volume>639</volume><issue-id pub-id-type="pmc-issue-id">441252</issue-id><fpage>122951</fpage><lpage>122951</lpage><pub-history><event event-type="nihms-submitted"><date><day>05</day><month>05</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>25</day><month>05</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>25</day><month>05</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 13:25:13.573"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1894879.pdf"/><abstract id="ABS1"><p id="P1">Thorough characterization of the plasma pharmacokinetics (PK) is a critical step in clinical development of novel therapeutics and is routinely performed for small molecules and biologics. However, there is a paucity of even basic characterization of PK for nanoparticle-based drug delivery systems. This has led to untested generalizations about how nanoparticle properties govern PK. Here, we present a meta-analysis of 100 nanoparticle formulations following IV administration in mice to identify any correlations between four PK parameters derived by non-compartmental analysis (NCA) and four cardinal properties of nanoparticles: PEGylation, zeta potential, size, and material. There was a statistically significant difference between the PK of particles stratified by nanoparticle properties. However, single linear regression between these properties and PK parameters showed poor predictability (r<sup>2</sup> &lt; 0.10 for all analyses), while multivariate regressions showed improved predictability (r<sup>2</sup> &gt; 0.38, except for t<sub>1/2</sub>). This suggests that no single nanoparticle property alone is even moderately predictive of PK, while the combination of multiple nanoparticle features does provide moderate predictive power. Improved reporting of nanoparticle properties will enable more accurate comparison between nanoformulations and will enhance our ability to predict <italic toggle="yes">in vivo</italic> behavior and design optimal nanoparticles.</p></abstract><abstract id="ABS2" abstract-type="graphical"><title>Graphical Abstract</title><p id="P2">
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="nihms-1894879-f0001.jpg"/>
</p></abstract><kwd-group><kwd>Pharmacokinetics</kwd><kwd>nanoparticles</kwd><kwd>non-compartmental analysis</kwd><kwd>meta-analysis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>